;

Auto Summaries - Epidemiology
Last updated: 2025 Jul 18
Total hit(s): 21657
S.No.
1
40619244
Erratum: "Coffee and green tea consumption with the risk of COVID-19 among the vaccine recipients in Japan: a prospective study" [J Epidemiol 34(9) (2024) 444-452].
N/A
J Epidemiol
2025 Jul 5
5.8
1
2
40674101
COVID-19 Pandemic and Posttreatment Breast Cancer Surveillance and Outcomes.
N/A
JAMA Oncol
2025 Jul 17
13.86
1
3
40654050
Excess respiratory, circulatory, neoplasm and other mortality rates during the Covid-19 pandemic in the EU and their implications.
N/A
Epidemiol Infect
2025 Jul 14
2.01
1
4
40646192
Saliva's role in COVID-19 transmission and innovation.
N/A
Br Dent J
2025 Jul
1.07
1
5
40488589
Cutaneous Squamous Cell Carcinoma in the Post-COVID-19 Era: Dramatic Increase of New Cases in 2023 in Two German Skin Tumour Centers.
N/A
Acta Derm Venereol
2025 Jun 9
3.01
1
6
40459240
Differentiating SARS-CoV-2 antibody responses between infection and vaccination: challenges for epidemiological research.
N/A
J Infect Dis
2025 Jun 3
4.73
1
7
40579769
Impact of the COVID-19 pandemic on TB epidemiology.
N/A
Int J Tuberc Lung Dis
2025 Jun 27
4.1
1
8
40560295
Obstructive sleep apnea is a risk factor for incident COVID-19 infection.
N/A
Sleep Breath
2025 Jun 25
2.42
1
9
40457307
Correction: Assessing the impact of an evidence- and consensus-based guideline for controlling SARS-CoV-2 transmission in German schools on decision-making processes: a multi-component qualitative analysis.
N/A
Health Res Policy Syst
2025 Jun 2
5.5
1
10
40525456
Comparative Analysis of Instantaneous Reproduction Number Using ILI (Influenza-Like Illness) Surveillance Data in the Republic of Korea: Before, During, and After the COVID-19 Pandemic.
N/A
Asia Pac J Public Health
2025 Jun 17
1.85
1
11
40104250
A Canadian multi-province study of COVID-19 vaccine coverage along area-level social determinants in 2021.
N/A
Public Health Pract (Oxf)
2025 Jun
3.4
1
12
40343624
Correction: Routine vaccination coverage at ages 2 and 7, before, during, and after the COVID-19 pandemic: Results from the STARVAX surveillance system.
N/A
Can J Public Health
2025 May 9
2.3
1
13
40451512
Cardiovascular Events in hospitalized COVID-19 patients: incidence, in-hospital mortality and fatality rates. Results from the HERICCO study by the Working Group of Echocardiology of the Hellenic Cardiology Society.
N/A
Hellenic J Cardiol
2025 May 30
6.8
1
14
40441063
Corrigendum to "Underlying health biases in previously-infected SARS-CoV-2 vaccination recipients: A cohort study" [J Infect 90 (2025) 106497].
N/A
J Infect
2025 May 28
5.1
1
15
40405815
Data for action - description of the automated COVID-19 surveillance system in Denmark and lessons learnt, January 2020 to June 2024 - CORRIGENDUM.
N/A
Epidemiol Infect
2025 May 23
2.01
1
16
40490390
Preventing COVID-19 in Correctional Facilities: The Impact of Rapid Antigen Tests on Early Detection and Infection Control.
N/A
Infect Chemother
2025 May 22
1.94
1
17
40376806
Isolating the burden of transmission-based precautions for COVID-19: walk-in clinic-based healthcare personnel perspectives.
N/A
Infect Control Hosp Epidemiol
2025 May 16
2.66
1
18
40383396
Novel coronaviruses identified in livestock: The urgent need to enhance coronavirus surveillance to mitigate zoonotic risks.
N/A
J Infect
2025 May 16
5.1
1
19
40173425
Erratum: Comparison of the Test-negative Design and Cohort Design With Explicit Target Trial Emulation for Evaluating COVID-19 Vaccine Effectiveness.
N/A
Epidemiology
2025 May 1
4.65
1
20
40203252
Sexually Transmitted Infection Cases During COVID-19: Implications for Public Health.
N/A
Am J Public Health
2025 May
4.21
1
21
40183376
A plain language summary of the available safety data for the BNT162b2 COVID-19 vaccine: development, approval, and surveillance of use.
N/A
Expert Rev Vaccines
2025 Apr 4
4.37
1
22
40287005
Comment on: "COVID-19 Vaccination and Ocular Adverse Events: A Self-Controlled Case Series Study From the Entire South Korean Population".
N/A
Am J Ophthalmol
2025 Apr 24
7.1
1
23
40264377
Severe COVID-19 and inactivated vaccine in diabetic patients with SARS-CoV-2 infection.
N/A
Chin Med J (Engl)
2025 Apr 23
1.053
1
24
40122247
Rapid spread of Candida auris in China after COVID-19.
N/A
J Infect
2025 Apr
5.1
1
25
40159907
SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022 - CORRIGENDUM.
N/A
Epidemiol Infect
2025 Mar 31
2.01
1